Platelet Rich Plasma and Wound Healing After Cesarean Section - Trial NCT04669353
Access comprehensive clinical trial information for NCT04669353 through Pure Global AI's free database. This Phase 4 trial is sponsored by Menoufia University and is currently Completed. The study focuses on Infection. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Menoufia University
Timeline & Enrollment
Phase 4
Apr 01, 2018
Dec 30, 2020
Primary Outcome
Redness, Edema, Ecchymosis, Discharge, Approximation scale changes
Summary
Objective: To assess the effect of autologous Platelet Rich Plasma (PRP) on wound healing and
 pain perception in high risk women undergoing cesarean sections in a low resource setting.
 
 Methods: This was a randomized controlled trial of 200 women who attended the outpatient
 clinic of Menoufia University Hospital for elective cesarean surgery. The women were randomly
 assigned to two groups. The intervention group received PRP after surgery, whereas the
 control group received the usual care. Outcomes included Redness, Edema, Ecchymosis,
 Discharge, Approximation (REEDA) scale, Vancouver scar scale (VSS), and the visual analog
 scale (VAS).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04669353
Non-Device Trial